Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TeenVIBE: Kurvelo in Female Adolescents at Risk of Suicide
NCT07544966Phase 4Not yet recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethinyl estradiol in major depressive disorder (MDD), irritability, sponsored by University of North Carolina at Chapel Hill. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ethinyl estradiol
03
Conditions
major depressive disorder (MDD)irritability
Beyond the preview
Go deeper on NCT07544966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07544966.